Partial Agonism: Mechanisms Based on Ligand-Receptor Interactions and on Stimulus-Response Coupling
- 1 January 1999
- journal article
- review article
- Published by Taylor & Francis in Journal of Receptors and Signal Transduction
- Vol. 19 (1-4), 597-629
- https://doi.org/10.3109/10799899909036675
Abstract
Substances eliciting, at very high concentrations, a lower maximal response of a particular biological system than a defined standard, are defined as partial agonists. The convention rests on the definition of a standard substance that achieves a 'full' maximal response; partial agonism being, therefore, relative. Various mechanisms lie behind this phenomenon: 1. Receptor-related mechanisms: the agonist-receptor complex exists in several conformational states from which only one, or only a few, activate the cell signaling pathway. This may occur when the receptor itself, or the agonist, exists in multiple states (e.g., in the form of enantiomers or stereoisomers), or when the agonist-receptor complex changes its conformation (receptor switch: two-state model of receptor activation). Furthermore, a steric hindrance by a 'wrong-way binding' of a part of the agonist's molecules may prevent the full 'correct' occupancy of receptors. 2. Mechanisms based on the efficacy of the stimulus-response coupling. The efficacy is then proportional to the sum of probabilities that receptors in individual states activate the cell-signaling pathway. Doses (concentrations) eliciting the half maximal response (EC50), or similar response sensitivity parameters, are not included in the definition of partial agonism. However, tight correlations exist between maximal response and EC50 in many, but not all, generic groups of agonistically acting substances. These relationships are frequently linear; intercepts and slopes of these 'E, KE plots' are characteristic for individual, putative mechanisms. Dose-response curves of partial agonists are akin to those obtained for a response to a full agonist after a stepwise partial inactivation of receptors by an irreversible inhibitor. Also, the E, KE plots obtained in these instances are similar to those of partial agonists. The receptor reserve, rather vaguely defined in early reports, is therefore closely linked to the phenomenon of partial agonism.Keywords
This publication has 19 references indexed in Scilit:
- Agonist-specific receptor conformations: Ligands create bias in already complex systemsTrends in Pharmacological Sciences, 1997
- The Role of Lipophilicity in Biological Response to Drugs and Endogenous LigandsPublished by Wiley ,1996
- Minireview: Mutations and Diseases of G Protein Coupled ReceptorsJournal of Receptors and Signal Transduction, 1995
- Pharmacological versus binding analysis of receptor systems: How do they interplay? Myometrial cell receptors for oxytocin as a paradigmCellular and Molecular Life Sciences, 1991
- Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?Journal of Theoretical Biology, 1989
- Pharmacological Approaches to the Identification and Classification of Myometrial Oxytocin ReceptorsJournal of Receptor Research, 1988
- Dose-response models: similarity with population growth dynamicsTrends in Pharmacological Sciences, 1987
- Operational models of pharmacological agonismProceedings of the Royal Society of London. B. Biological Sciences, 1983
- A theory of drug action based on the rate of drug-receptor combinationProceedings of the Royal Society of London. B. Biological Sciences, 1961
- Optical Isomerism and Pharmacological Action, a GeneralizationScience, 1956